Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores
Status:
Withdrawn
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This is a multiple center, randomized, double-blind, placebo-controlled study to evaluate the
safety and efficacy of brivoligide injection administered intrathecally before surgery in
patients with high Pain Catastrophizing Scale (PCS) scores undergoing mastectomy with
immediate tissue expander or implant placement.